Cargando…

Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China

Objective: Cognitive symptoms in major depressive disorder (MDD) are common and may negatively impact clinical and functional outcomes. The Prospective Research Observation to Assess Cognition in Treated patients with MDD (PROACT) study aimed to assess the prevalence and course of cognitive symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Gang, Si, Tian-Mei, Li, Lingjiang, Fang, Yiru, Wang, Chun-Xue, Wang, Li-Na, Tan, Kristin Hui Xian, Ettrup, Anders, Eriksen, Hanne-Lise Falgreen, Luo, Si, Ge, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612986/ https://www.ncbi.nlm.nih.gov/pubmed/31308667 http://dx.doi.org/10.2147/NDT.S195505

Ejemplares similares

Anxiety symptoms in working patients with major depressive disorder treated with vortioxetine: associations with clinical and treatment outcomes in the AtWoRC study
por: Chokka, Pratap, et al.
Publicado: (2021)

Early life predictors of intelligence in young adulthood and middle age
por: Flensborg-Madsen, Trine, et al.
Publicado: (2020)

Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study
por: Haro, Josep Maria, et al.
Publicado: (2019)

Predictive potential of somatic symptoms for the identification of subthreshold depression and major depressive disorder in primary care settings
por: Li, Xiuwen, et al.
Publicado: (2023)

From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder
por: Liu, Bangshan, et al.
Publicado: (2017)

Effects of Tobacco Smoking in Pregnancy on Offspring Intelligence at the Age of 5
por: Falgreen Eriksen, Hanne-Lise, et al.
Publicado: (2012)

Predictors of Intelligence at the Age of 5: Family, Pregnancy and Birth Characteristics, Postnatal Influences, and Postnatal Growth
por: Eriksen, Hanne-Lise Falgreen, et al.
Publicado: (2013)

Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study
por: Baune, Bernhard T, et al.
Publicado: (2021)

Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study
por: Wang, Gang, et al.
Publicado: (2020)

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population
por: Jiang, Kaida, et al.
Publicado: (2017)

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study
por: Vieta, Eduard, et al.
Publicado: (2019)

Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects
por: Papalexi, Eugenia, et al.
Publicado: (2022)

Are subsyndromal symptomatic depression and major depressive disorder distinct disorders?
por: Yi, Zhenghui, et al.
Publicado: (2012)

Mapping the Presence of Anxiety Symptoms in Adults With Major Depressive Disorder
por: Ge, Fenfen, et al.
Publicado: (2021)

Differential gene expression in patients with subsyndromal symptomatic depression and major depressive disorder
por: Yang, Chengqing, et al.
Publicado: (2017)

Identifying the Subtypes of Major Depressive Disorder Based on Somatic Symptoms: A Longitudinal Study Using Latent Profile Analysis
por: Wu, Xiaohui, et al.
Publicado: (2022)

Screening Depressive Symptoms and Incident Major Depressive Disorder Among Chinese Community Residents Using a Mobile App–Based Integrated Mental Health Care Model: Cohort Study
por: Zhang, Huimin, et al.
Publicado: (2022)

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study
por: Rancans, Elmars, et al.
Publicado: (2020)

Gender differences in the association between anxiety symptoms and thyroid hormones in young patients with first-episode and drug naïve major depressive disorder
por: Zhao, Ying, et al.
Publicado: (2023)

Gene expression signatures differentiating major depressive disorder from subsyndromal symptomatic depression
por: Hu, Guoqin, et al.
Publicado: (2021)

Surface Vulnerability of Cerebral Cortex to Major Depressive Disorder
por: Peng, Daihui, et al.
Publicado: (2015)

Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
por: Li, Zezhi, et al.
Publicado: (2021)

Program of algorithm for pharmacological treatment of major depressive disorder in China: Benefits or not?
por: Zhu, Yuncheng, et al.
Publicado: (2023)

Comparative study of major depressive symptoms among pregnant women by employment status
por: Fall, Aïssatou, et al.
Publicado: (2013)

Gender Differences in Dysfunctional Attitudes in Major Depressive Disorder
por: Qin, Xuemei, et al.
Publicado: (2020)

Identification of IL6 as a susceptibility gene for major depressive disorder
por: Zhang, Chen, et al.
Publicado: (2016)

Evidence for Progressive Cognitive Deficits in Patients With Major Depressive Disorder
por: Liu, Jin, et al.
Publicado: (2021)

Exploration of Major Cognitive Deficits in Medication-Free Patients With Major Depressive Disorder
por: Liu, Jin, et al.
Publicado: (2019)

Correction: Surface Vulnerability of Cerebral Cortex to Major Depressive Disorder
por: Peng, Daihui, et al.
Publicado: (2015)

Comparison of Residual Depressive Symptoms, Functioning, and Quality of Life Between Patients with Recurrent Depression and First Episode Depression After Acute Treatment in China
por: Zu, Si, et al.
Publicado: (2021)

Corrigendum: Gender Differences in Dysfunctional Attitudes in Major Depressive Disorder
por: Qin, Xuemei, et al.
Publicado: (2020)

Low to Moderate Average Alcohol Consumption and Binge Drinking in Early Pregnancy: Effects on Choice Reaction Time and Information Processing Time in Five-Year-Old Children
por: Kilburn, Tina R., et al.
Publicado: (2015)

Blood-Based Gene Expression Profiles Models for Classification of Subsyndromal Symptomatic Depression and Major Depressive Disorder
por: Yi, Zhenghui, et al.
Publicado: (2012)

Linked patterns of symptoms and cognition with brain controllability in major depressive disorder
por: Li, Q., et al.
Publicado: (2023)

Prediction of Clinical Outcomes With EEG Microstate in Patients With Major Depressive Disorder
por: Yan, Danfeng, et al.
Publicado: (2021)

Depressive symptoms and major adverse cardiovascular events: 12-month follow-up in patients undergoing angiography
por: Dadkhah-Tirani, Heidar, et al.
Publicado: (2020)

Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder
por: Huang, Juan, et al.
Publicado: (2023)

Association between childhood trauma and medication adherence among patients with major depressive disorder: the moderating role of resilience
por: Wang, Hongqiong, et al.
Publicado: (2022)

The Impact of Residual Symptoms in Major Depression
por: Israel, Joshua A.
Publicado: (2010)

Nuclear receptors modulate inflammasomes in the pathophysiology and treatment of major depressive disorder
por: Wang, Han, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f4hdd2qhoir2961hlqn4kj3m3s